Eric S. Maller

Lower Malignancy Rates in Renal Allograft Recipients Converted to Sirolimus-Based, Calcineurin Inhibitor-Free Immunotherapy: 24-Month Results From the CONVERT Trial

Josefina Alberú, M.D. Pascoe, Josep M. Campistol et al. · Transplantation · 2011 · 222 citations

Medicine, Immunology, Nephrology +17

Ulcer formation with low-dose enteric-coated aspirin and the effect of COX-2 selective inhibition: A double-blind trial

Loren Laine, Eric S. Maller, Chang Yu et al. · Gastroenterology · 2004 · 196 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

De Novo Sirolimus and Reduced-Dose Tacrolimus Versus Standard-Dose Tacrolimus After Liver Transplantation: The 2000–2003 Phase II Prospective Randomized Trial

Sumeet K. Asrani, Russell H. Wiesner, J.F. Trotter et al. · American Journal of Transplantation · 2014 · 98 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Efficacy and safety of tofacitinib dose de‐escalation and dose escalation for patients with ulcerative colitis: results from OCTAVE Open

Bruce E. Sands, Alessandro Armuzzi, John K. Marshall et al. · Alimentary Pharmacology & Therapeutics · 2019 · 85 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Azathioprine and 6-Mercaptopurine for the Treatment of Perianal Crohn's Disease in Children

W C Jeshion, Kelly L. Larsen, Abbas F. Jawad et al. · Journal of Clinical Gastroenterology · 2000 · 61 citations

Medicine, Pediatrics, Pharmacotherapy +11